Tower View Wealth Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$2.16M |
| 2 |
Advanced Micro Devices
AMD
|
+$1.62M |
| 3 |
Cellebrite
CLBT
|
+$1.24M |
| 4 |
Arm
ARM
|
+$978K |
| 5 |
Qualcomm
QCOM
|
+$286K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Deere & Co
DE
|
+$4.82M |
| 2 |
Canadian Natural Resources
CNQ
|
+$4.17M |
| 3 |
NVIDIA
NVDA
|
+$1.48M |
| 4 |
Eli Lilly
LLY
|
+$1.2M |
| 5 |
Hershey
HSY
|
+$579K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.33% |
| 2 | Healthcare | 15.48% |
| 3 | Industrials | 12.11% |
| 4 | Consumer Discretionary | 11.52% |
| 5 | Financials | 7.11% |
Similar funds
Tower View Wealth Management's Q1 2024 Portfolio in Review
As of Q1 2024, Tower View Wealth Management held 203 positions worth $171M, up 5.9% from $161M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Tower View Wealth Management withdrew a net $7.8M in Q1 2024, closing 11 positions and reducing 53 holdings. Its most notable exit was Deere & Co, an estimated $4.82M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Tower View Wealth Management opened a new position in Regeneron Pharmaceuticals worth $2.18M.
- Tower View Wealth Management's largest Q1 2024 buy was Regeneron Pharmaceuticals: 2,268 shares worth $2.18M.
- Tower View Wealth Management added most to Qualcomm in Q1 2024, an estimated $286K increase.
- Tower View Wealth Management's biggest Q1 2024 reduction was Canadian Natural Resources, cutting an estimated $4.17M.
- Tower View Wealth Management fully exited Deere & Co in Q1 2024, selling an estimated $4.82M.
- Tower View Wealth Management's ten largest holdings make up 35% of its $171M portfolio in Q1 2024.
- Tower View Wealth Management opened 21 new positions and closed 11 in Q1 2024.
- Tower View Wealth Management's portfolio value rose 5.9% quarter-over-quarter to $171M.
Based on Tower View Wealth Management's 13F filing for Q1 2024, filed 29 Apr 2024.